Peter Attia· MD
Scott Gottlieb the head of the FDA has basically said enough is enough when your patents are over you've got to turn all this stuff over we got to get the generics going right away
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Scott Gottlieb the head of the FDA has basically said enough is enough when your patents are over you've got to turn all this stuff over we got to get the generics going right away
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.